Structural insights into the polypharmacological activity of quercetin on serine/threonine kinases

References

• Blume-JensenPHunterTOncogenic kinase signallingNature2001411683535536511357143
   PubMed Web of Science ®Google Scholar
• Tantamango-BartleyYJaceldo-SieglKFanJFraserGVegetarian diets and the incidence of cancer in a low-risk populationCancer Epidemiol Biomarkers Prev201322228629423169929
   PubMed Web of Science ®Google Scholar
• RossJAKasumCMDietary flavonoids: bioavailability, metabolic effects, and safetyAnnu Rev Nutr2002221193412055336
   PubMed Web of Science ®Google Scholar
• PaceGLimaPVianelloFPolyphenols in fruits and vegetables and its effect on human healthFood Nutr Sci20145510651082
   Google Scholar
• BootsAWHaenenGRBastAHealth effects of quercetin: from antioxidant to nutraceuticalEur J Pharmacol20085852–332533718417116
   PubMed Web of Science ®Google Scholar
• BouktaibMAtmaniARolandoCRegio- and stereoselective synthesis of the major metabolite of quercetin, quercetin-3-O-β-D-glucuronideTetrahedron Lett2002433562636266
   Web of Science ®Google Scholar
• DajasFLife or death: neuroprotective and anticancer effects of quercetinJ Ethnopharmacol2012143238339622820241
   PubMed Web of Science ®Google Scholar
• CossarizzaAGibelliniLPintiMQuercetin and cancer chemo-preventionEvid Based Complementary Altern Med20112011591356
   PubMed Web of Science ®Google Scholar
• RussoMSpagnuoloCTedescoIBilottoSRussoGLThe flavonoid quercetin in disease prevention and therapy: facts and fanciesBiochem Pharmacol201283161521856292
   PubMed Web of Science ®Google Scholar
• ShenXSiYWangZWangJGuoYZhangXQuercetin inhibits the growth of human gastric cancer stem cells by inducing mitochondrial-dependent apoptosis through the inhibition of PI3K/Akt signalingInt J Mol Med201638261962627278820
   PubMed Web of Science ®Google Scholar
• DevipriyaSGanapathyVShyamaladeviCSSuppression of tumor growth and invasion in 9,10 dimethyl benz(a) anthracene induced mammary carcinoma by the plant bioflavonoid quercetinChem Biol Interact2006162210611316846595
   PubMed Web of Science ®Google Scholar
• FerryDRSmithAMalkhandiJPhase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibitionClin Cancer Res1996246596689816216
   PubMed Web of Science ®Google Scholar
• ChoiJKimJLeeJInduction of cell cycle arrest and apoptosis in human breast cancer cells by quercetinInt J Oncol200119483784411562764
   PubMed Web of Science ®Google Scholar
• Pawlikowska-PawlegaBJakubowicz-GilJRzymowskaJGawronAThe effect of quercetin on apoptosis and necrosis induction in human colon adenocarcinoma cell line LS180Folia Histochem Cytobiol200139221721811374833
   PubMed Web of Science ®Google Scholar
• AsaumJMatsuzakiHKawasakSEffects of quercetin on the cell growth and the intracellular accumulation and retention of adriamycinAnticancer Res20002042477248310953314
   PubMed Web of Science ®Google Scholar
• DamianakiABakogeorgouEKampaMPotent inhibitory action of red wine polyphenols on human breast cancer cellsJ Cell Biochem200078342944110861841
   PubMed Web of Science ®Google Scholar
• LamsonDWBrignallMSAntioxidants and cancer, part 3: quercetinAltern Med Rev20005319620810869101
   PubMedGoogle Scholar
• BolyRGrasTLamkamiTQuercetin inhibits a large panel of kinases implicated in cancer cell biologyInt J Oncol201138383384221206969
   PubMed Web of Science ®Google Scholar
• LeeLTHuangYTHwangJJBlockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cellsAnticancer Res20022231615162712168845
   PubMed Web of Science ®Google Scholar
• ValentováKVrbaJBancířováMIsoquercitrin: pharmacology, toxicology, and metabolismFood Chem Toxicol20146826728224680690
   PubMed Web of Science ®Google Scholar
• YouHJAhnHJJiGETransformation of rutin to antiproliferative quercetin-3-glucoside by Aspergillus nigerJ Agric Food Chem20105820108861089220886886
   PubMed Web of Science ®Google Scholar
• LeeJHanS-IYunJ-HQuercetin 3-O-glucoside suppresses epidermal growth factor–induced migration by inhibiting EGFR signaling in pancreatic cancer cellsTumor Biol2015361293859393
   PubMedGoogle Scholar
• GoldsmithEJAkellaRMinXSubstrate and docking interactions in serine/threonine protein kinasesChem Rev2007107115065508117949044
   PubMed Web of Science ®Google Scholar
• SliwoskiGKothiwaleSMeilerJLoweEWJrComputational methods in drug discoveryPharmacol Rev201466133439524381236
   PubMed Web of Science ®Google Scholar
• AnighoroABajorathJRastelliGPolypharmacology: challenges and opportunities in drug discoveryJ Med Chem201457197874788724946140
   PubMed Web of Science ®Google Scholar
• SussmanJLLinDJiangJProtein data bank (PDB): database of three-dimensional structural information of biological macromoleculesActa Crystallogr D Biol Crystallogr1998546 I1078108410089483
   PubMedGoogle Scholar
• Schrödinger, LLCSchrödinger Suite 2015-3 Protein Preparation WizardEpik, version 3.3New York, NYSchrödinger, LLC2015
   Google Scholar
• Schrödinger, LLCImpact, version 6.8New York, NYSchrödinger, LLC2015
   Google Scholar
• Schrödinger, LLCPrime, version 4.1New York, NYSchrödinger, LLC2015
   Google Scholar
• SastryGMAdzhigireyMDayTAnnabhimojuRShermanWProtein and ligand preparation: parameters, protocols, and influence on virtual screening enrichmentsJ Comput Aided Mol Des201327322123423579614
   PubMed Web of Science ®Google Scholar
• WangYXiaoJSuzekTOZhangJWangJBryantSHPubChem: a public information system for analyzing bioactivities of small moleculesNucleic Acids Res200937Web Server issueW623W63319498078
   PubMed Web of Science ®Google Scholar
• Schrödinger, LLCLigPrep, version 3.5New York, NYSchrödinger, LLC2015
   Google Scholar
• FriesnerRAMurphyRBRepaskyMPExtra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexesJ Med Chem200649216177619617034125
   PubMed Web of Science ®Google Scholar
• LiJAbelRZhuKCaoYZhaoSFriesnerRAThe VSGB 2.0 model: a next generation energy model for high resolution protein structure modelingProteins201179102794281221905107
   PubMed Web of Science ®Google Scholar
• MasoVCalgarottoAKFranchiGCJrMultitarget effects of quercetin in leukemiaCancer Prev Res (Phila)20147121240125025293876
   PubMed Web of Science ®Google Scholar
• RhodesNHeerdingDADuckettDRCharacterization of an Akt kinase inhibitor with potent pharmacodynamic and antitumor activityCancer Res20086872366237418381444
   PubMed Web of Science ®Google Scholar
• MorenoLMarshallLVPearsonADJA phase I trial of AT9283 (a selective inhibitor of aurora kinases) in children and adolescents with solid tumors: a cancer research UK studyClin Cancer Res201521226727325370467
   PubMed Web of Science ®Google Scholar
• SapkotaGPCummingsLNewellFSBI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivoBiochem J20074011293817040210
   PubMed Web of Science ®Google Scholar
• TraxlerPFuretPStrategies toward the design of novel and selective protein tyrosine kinase inhibitorsPharmacol Ther1999822–319520610454197
   PubMed Web of Science ®Google Scholar
• ZabludoffSDDengCGrondineMRAZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapiesMol Cancer Ther2008792955296618790776
   PubMed Web of Science ®Google Scholar
• CasagrandeFDarbonJ-MEffects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK11Biochem Pharmacol200161101205121511322924
   PubMed Web of Science ®Google Scholar
• KimMCLeeHJLimBQuercetin induces apoptosis by inhibiting MAPKs and TRPM7 channels in AGS cellsInt J Mol Med20143361657166324647664
   PubMed Web of Science ®Google Scholar
• KumarSKLaPlantBChngWJDinaciclib, a novel CDK inhibitor, demonstrates encouraging single agent activity in patients with relapsed multiple myelomaBlood2014125344344825395429
   PubMed Web of Science ®Google Scholar
• WongDJLRobertLAtefiMSAntitumor activity of the ERK inhibitor SCH772984 [corrected] against BRAF mutant, NRAS mutant and wild-type melanomaMol Cancer20141319425142146
   PubMed Web of Science ®Google Scholar
• PargellisCTongLChurchillLInhibition of p38 MAP kinase by utilizing a novel allosteric binding siteNat Struct Biol20029426827211896401
   PubMedGoogle Scholar
• CerboneAToaldoCPizzimentiSAS601245, an anti-inflammatory JNK inhibitor, and clofibrate have a synergistic effect in inducing cell responses and in affecting the gene expression profile in CaCo-2 colon cancer cellsPPAR Res2012201226975122619672
   PubMed Web of Science ®Google Scholar
• NaujokOLentesJDiekmannUDavenportCLenzenSCytotoxicity and activation of the Wnt/beta-catenin pathway in mouse embryonic stem cells treated with four GSK3 inhibitorsBMC Res Notes20147127324779365
   PubMedGoogle Scholar
• LeeKWKangNJHeoY-SRaf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wineCancer Res200868394695518245498
   PubMed Web of Science ®Google Scholar
• AngioliniMTargeting the DFG-in kinase conformation: a new trend emerging from a patent analysisFuture Med Chem20113330933721446845
   PubMed Web of Science ®Google Scholar
• PengY-HShiaoH-YTuC-HProtein kinase inhibitor design by targeting the Asp-Phe-Gly (DFG) motif: the role of the DFG motif in the design of epidermal growth factor receptor inhibitorsJ Med Chem201356103889390323611691
   PubMed Web of Science ®Google Scholar
• StabenSTSiuMGoldsmithRStructure-based design of thienobenzoxepin inhibitors of PI3-kinaseBioorg Med Chem Lett201121134054405821636270
   PubMed Web of Science ®Google Scholar
• LawrenceHRMartinMPLuoYDevelopment of o-chlorophenyl substituted pyrimidines as exceptionally potent aurora kinase inhibitorsJ Med Chem201255177392741622803810
   PubMed Web of Science ®Google Scholar
• ZapfCWGerstenbergerBSXingLCovalent inhibitors of interleukin-2 inducible T cell kinase (itk) with nanomolar potency in a whole-blood assayJ Med Chem20125522100471006323098091
   PubMed Web of Science ®Google Scholar
• AlevyYGPatelACRomeroAGIL-13–induced airway mucus production is attenuated by MAPK13 inhibitionJ Clin Invest2012122124555456823187130
   PubMed Web of Science ®Google Scholar
• YokoyamaTKosakaYMizuguchiMStructural insight into the interactions between death-associated protein kinase 1 and natural flavonoidsJ Med Chem201558187400740826322379
   PubMed Web of Science ®Google Scholar
• PaulkeAEckertGPSchubert-ZsilaveczMWurglicsMIsoquercitrin provides better bioavailability than quercetin: comparison of quercetin metabolites in body tissue and brain sections after six days administration of isoquercitrin and quercetinPharmazie2012671299199623346761
   PubMed Web of Science ®Google Scholar
• GeeJMDuPontMSDayAJPlumbGWWilliamsonGJohnsonITIntestinal transport of quercetin glycosides in rats involves both deglycosylation and interaction with the hexose transport pathwayJ Nutr20001302765277111053519
   PubMed Web of Science ®Google Scholar